Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Pharmacists play a crucial role in patient education and personalized care.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib may help treat severe hair loss, but more research is needed.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Topical corticosteroids are the best initial treatment for children with Alopecia Areata.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Beard alopecia areata causes patchy beard hair loss, often treatable with janus kinase inhibitors.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.